Skip to Content
Merck
  • Coformer screening using thermal analysis based on binary phase diagrams.

Coformer screening using thermal analysis based on binary phase diagrams.

Pharmaceutical research (2014-02-14)
Hiroyuki Yamashita, Yutaka Hirakura, Masamichi Yuda, Katsuhide Terada
ABSTRACT

The advent of cocrystals has demonstrated a growing need for efficient and comprehensive coformer screening in search of better development forms, including salt forms. Here, we investigated a coformer screening system for salts and cocrystals based on binary phase diagrams using thermal analysis and examined the effectiveness of the method. Indomethacin and tenoxicam were used as models of active pharmaceutical ingredients (APIs). Physical mixtures of an API and 42 kinds of coformers were analyzed using Differential Scanning Calorimetry (DSC) and X-ray DSC. We also conducted coformer screening using a conventional slurry method and compared these results with those from the thermal analysis method and previous studies. Compared with the slurry method, the thermal analysis method was a high-performance screening system, particularly for APIs with low solubility and/or propensity to form solvates. However, this method faced hurdles for screening coformers combined with an API in the presence of kinetic hindrance for salt or cocrystal formation during heating or if there is degradation near the metastable eutectic temperature. The thermal analysis and slurry methods are considered complementary to each other for coformer screening. Feasibility of the thermal analysis method in drug discovery practice is ensured given its small scale and high throughput.

MATERIALS
Product Number
Brand
Product Description

Supelco
Niacinamide, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Melting point standard 121-123°C, analytical standard
Supelco
4-Hydroxybenzoic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Citric acid, Anhydrous, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Glutamic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Benzoic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Arginine, Pharmaceutical Secondary Standard; Certified Reference Material
Sorbic acid, European Pharmacopoeia (EP) Reference Standard
Nicotinamide, European Pharmacopoeia (EP) Reference Standard
Supelco
Mettler-Toledo Calibration substance ME 51143091, Saccharin, traceable to primary standards (LGC)
Sigma-Aldrich
L-Arginine, 99%, FCC, FG
Sigma-Aldrich
Citric acid, ACS reagent, ≥99.5%
Supelco
Stearic Acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Benzoic acid, purified by sublimation, ≥99%
Sigma-Aldrich
Adipic acid, 99%
Sigma-Aldrich
Anthranilic acid, reagent grade, ≥98%
Supelco
Benzoic acid, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
N-Methyl-D-glucamine, 99.0-100.5% (titration)
Sigma-Aldrich
2,5-Dihydroxybenzoic acid, 98%
Sigma-Aldrich
Citric acid, ≥99.5%, FCC, FG
Supelco
2,5-Dihydroxybenzoic acid, >99.0% (HPLC)
Sigma-Aldrich
Urea, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%, 99.0-101.0% (calc. on dry substance)
Sigma-Aldrich
Anthranilic acid, puriss. p.a., ≥99.5% (T)
Sigma-Aldrich
Sorbic acid, tested according to Ph. Eur.
Supelco
Stearic acid, analytical standard
Sigma-Aldrich
Urea, BioUltra, 99% (T)
Sigma-Aldrich
Fumaric acid, ≥99.0% (T)
Sigma-Aldrich
Benzoic acid, ACS reagent, ≥99.5%
Sigma-Aldrich
4-Hydroxybenzoic acid, ReagentPlus®, 99%
Sigma-Aldrich
Urea, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%